Atara Biotherapeutics: Q1 Earnings Snapshot

THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Monday reported a loss of $74.8 million in its first quarter.

On a per-share basis, the Thousand Oaks, California-based company said it had a loss of 72 cents.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 40 cents per share.

The drug developer posted revenue of $1.2 million in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $37.7 million.

In the final minutes of trading on Monday, the company’s shares hit $2.98. A year ago, they were trading at $6.92.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on ATRA at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up